Continuous innovation, increasing collaboration between pharmaceutical and nutrition companies, and a growing emphasis on integrated care are expected to drive long-term growth
Canadian Considerations for Ongoing Treatment Canadian users should be aware of several factors specific to our healthcare context
A provider should review your symptoms, hormone markers, blood sugar status, body composition goals, medications, and medical history before recommending a peptide plan
While observational findings of that magnitude should always be interpreted cautiously, it raises an important hypothesis that GLP-1 therapies may be addressing several interconnected disease pathways simultaneously obesity, inflammation, cardiometabolic dysfunction, and possibly thrombosis, he continued